EA201170199A1 - Интравагинальные устройства с жёсткой подложкой, способы их получения и применения - Google Patents

Интравагинальные устройства с жёсткой подложкой, способы их получения и применения

Info

Publication number
EA201170199A1
EA201170199A1 EA201170199A EA201170199A EA201170199A1 EA 201170199 A1 EA201170199 A1 EA 201170199A1 EA 201170199 A EA201170199 A EA 201170199A EA 201170199 A EA201170199 A EA 201170199A EA 201170199 A1 EA201170199 A1 EA 201170199A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
reception
application
hard substrate
devices
Prior art date
Application number
EA201170199A
Other languages
English (en)
Other versions
EA021371B1 (ru
Inventor
Салах Ю. Ахмед
Цзясян Цао
Original Assignee
Тева Вимен'С Хелс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тева Вимен'С Хелс, Инк. filed Critical Тева Вимен'С Хелс, Инк.
Publication of EA201170199A1 publication Critical patent/EA201170199A1/ru
Publication of EA021371B1 publication Critical patent/EA021371B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к интравагинальным устройствам с жесткой подложкой, способам получения и применениям указанных устройств. Устройства содержат (а) жесткую подложку, имеющую твердость по Шору А по меньшей мере примерно 20 и прочность на разрыв по меньшей мере примерно 1 МПа, (b) матрицу и (с) активный агент, диспергированный в матрице, при этом матрица и подложка расположены в непосредственной близости, а устройство имеет кольцеобразную форму.
EA201170199A 2008-08-12 2009-08-12 Интравагинальные устройства с жёсткой подложкой, способы их получения и применения EA021371B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8831408P 2008-08-12 2008-08-12
PCT/US2009/004607 WO2010019226A1 (en) 2008-08-12 2009-08-12 Intravaginal devices with a rigid support, methods of making, and uses thereof

Publications (2)

Publication Number Publication Date
EA201170199A1 true EA201170199A1 (ru) 2011-08-30
EA021371B1 EA021371B1 (ru) 2015-06-30

Family

ID=41669143

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201170199A EA021371B1 (ru) 2008-08-12 2009-08-12 Интравагинальные устройства с жёсткой подложкой, способы их получения и применения

Country Status (9)

Country Link
US (1) US20100040671A1 (ru)
EP (1) EP2320871A4 (ru)
JP (1) JP2011530379A (ru)
AR (1) AR074528A1 (ru)
AU (1) AU2009282496B2 (ru)
CA (1) CA2733727A1 (ru)
EA (1) EA021371B1 (ru)
MX (1) MX338591B (ru)
WO (1) WO2010019226A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022207902A1 (fr) * 2021-04-01 2022-10-06 Ceva Sante Animale Compositions de progesterone a liberation controlee et leurs utilisations

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013000002A (es) * 2001-07-27 2013-04-29 Teva Womens Health Inc Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
CA2764063C (en) 2009-06-03 2019-05-14 Forsight Labs, Llc Anterior segment drug delivery
EP2547332B1 (en) * 2010-03-16 2018-08-29 Titan Pharmaceuticals, Inc. Heterogeneous implantable devices for drug delivery
JP5813093B2 (ja) * 2010-03-28 2015-11-17 エベストラ・インコーポレイテッドＥｖｅｓｔｒａ，Ｉｎｃ． 膣内薬物送達デバイス
CN103154016A (zh) * 2010-05-05 2013-06-12 特卫华妇女健康有限公司 使用具有逐渐降低的释放速率的单剂型减轻对象症状的方法
EA201291298A1 (ru) * 2010-06-22 2013-09-30 Тева Вимен'С Хелс, Инк. Интравагинальные устройства, содержащие антихолинергические агенты, и способы их изготовления
MX2013002016A (es) * 2010-08-20 2013-03-25 Teva Womens Health Inc Dispositivos intravaginales, metodos de fabricacion y usos de los mismos.
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
ZA201107786B (en) * 2010-10-26 2012-07-25 Maurice Roger Pope An inhibotor of pathogens
BR112013011744B1 (pt) * 2010-11-12 2021-04-27 The University Of Utah Research Foundation Dispositivo intravaginal para distribuição controlada de lubrificantes
US20120259160A1 (en) * 2011-04-11 2012-10-11 Nancy Karapasha Pessary device having improved comfort
US8926493B2 (en) * 2011-04-11 2015-01-06 The Procter & Gamble Company Pessary device
US9708371B2 (en) * 2011-08-17 2017-07-18 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
WO2013040426A2 (en) 2011-09-14 2013-03-21 Forsight Labs, Llc Ocular insert apparatus and methods
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
TW201332585A (zh) 2012-02-14 2013-08-16 Chemo Res S L 核鞘藥物遞送裝置
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN104884006B (zh) 2012-10-26 2017-12-15 弗赛特影像5股份有限公司 用于持续释放药物到眼睛的眼科系统
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JPWO2015041353A1 (ja) * 2013-09-20 2017-03-02 潤子 八木 子宮脱又は子宮下垂治療用リングペッサリー
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
EP3017809A1 (en) 2014-11-07 2016-05-11 Ferring B.V. Drug-device unit containing quinagolide
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
EP4129300A1 (en) 2016-03-23 2023-02-08 The University of North Carolina at Chapel Hill Geometrically complex intravaginal rings, systems and methods of making the same
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2023031218A1 (en) 2021-08-31 2023-03-09 Ferring B.V. Diagnosis and treatment of ectopic endometriosis

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
US4034749A (en) * 1973-12-06 1977-07-12 Schering Aktiengesellschaft Intrauterine contraceptive device
US3993072A (en) * 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
DE2445971A1 (de) * 1974-09-24 1976-04-08 Schering Ag Arzneimittelwirkstofftraeger ii
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US4286587A (en) * 1978-10-11 1981-09-01 Alza Corporation Vaginal drug delivery system made from polymer
US4215691A (en) * 1978-10-11 1980-08-05 Alza Corporation Vaginal contraceptive system made from block copolymer
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4308867A (en) * 1979-03-23 1982-01-05 Roseman Theodore J Two-member medicated device for rate-controlled administration of lipophilic pharmaceuticals
US4249531A (en) * 1979-07-05 1981-02-10 Alza Corporation Bioerodible system for delivering drug manufactured from poly(carboxylic acid)
US4402695A (en) * 1980-01-21 1983-09-06 Alza Corporation Device for delivering agent in vagina
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
NZ200564A (en) * 1982-05-10 1987-03-06 Ahi Operations Ltd Device for slowly releasing chemicals into body cavities of animals
US4961931A (en) * 1982-07-29 1990-10-09 Alza Corporation Method for the management of hyperplasia
US4629449A (en) * 1982-07-29 1986-12-16 Alza Corporation Vaginal dispenser for dispensing beneficial hormone
US4553972A (en) * 1983-05-20 1985-11-19 Syntex (U.S.A.) Inc. Disposable intravaginal contraceptive devices releasing 1-substituted imidazoles
NL8302103A (nl) * 1983-06-13 1985-01-02 Fundatech Sa Intravaginaal contraceptisch middel.
US4589880A (en) * 1983-07-14 1986-05-20 Southern Research Institute Disposable spermicide-releasing diaphragm
US4601893A (en) * 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
AU601170B2 (en) * 1985-06-19 1990-09-06 Fortune Capital Management B.V. Pessary
US4827946A (en) * 1988-01-06 1989-05-09 Steven Kaali Electrified vaginal ring
ES2148316T3 (es) * 1993-01-26 2000-10-16 Veos Uk Ltd Dispositivo vaginal desechable.
US6544546B1 (en) * 1995-07-04 2003-04-08 Akzo Nobel, N.V. Ring-shaped devices
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
TW358031B (en) * 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances
US6165166A (en) * 1997-04-25 2000-12-26 Schneider (Usa) Inc. Trilayer, extruded medical tubing and medical devices incorporating such tubing
US6572874B1 (en) * 1998-05-15 2003-06-03 Umd, Inc. Vaginal delivery of bisphosphonates
US7744916B2 (en) * 1997-06-11 2010-06-29 Umd, Inc. Coated vaginal device for delivery of anti-migraine and anti-nausea drugs
US20050276836A1 (en) * 1997-06-11 2005-12-15 Michelle Wilson Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
DE69929055T2 (de) * 1998-05-01 2006-07-20 Duramed Pharmaceuticals Inc., Cincinnati Verfahren zur spritzgussherstellung von vorrichtungen mit kontrollierter wirkstofffreisetzung und damit hergestellte vorrichtung
US6663639B1 (en) * 1999-06-22 2003-12-16 Ndo Surgical, Inc. Methods and devices for tissue reconfiguration
US7314716B2 (en) * 1999-11-19 2008-01-01 Mount Sinai School Of Medicine Gustducin γ subunit materials and methods
US6652450B2 (en) * 2001-01-23 2003-11-25 American Medical Systems, Inc. Implantable article and method for treating urinary incontinence using means for repositioning the implantable article
JP4273208B2 (ja) * 2001-03-30 2009-06-03 チッソ株式会社 婦人科疾患治療剤
CA2457526A1 (en) * 2001-08-29 2003-03-13 Umd, Inc. Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
US7004171B2 (en) * 2002-02-25 2006-02-28 Hi-Gienic Intra Vaginal Technologies Ltd. System for transvaginal drug delivery
US7833545B2 (en) * 2003-04-29 2010-11-16 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
US20060275364A1 (en) * 2005-05-26 2006-12-07 Ahmed Salah U Flexible Solid Dosage Forms and Methods of Making and Using the Same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022207902A1 (fr) * 2021-04-01 2022-10-06 Ceva Sante Animale Compositions de progesterone a liberation controlee et leurs utilisations

Also Published As

Publication number Publication date
AU2009282496B2 (en) 2015-08-06
WO2010019226A1 (en) 2010-02-18
EA021371B1 (ru) 2015-06-30
JP2011530379A (ja) 2011-12-22
EP2320871A1 (en) 2011-05-18
US20100040671A1 (en) 2010-02-18
CA2733727A1 (en) 2010-02-18
MX2011001605A (es) 2011-05-19
MX338591B (es) 2016-04-25
AU2009282496A1 (en) 2010-02-18
AR074528A1 (es) 2011-01-26
EP2320871A4 (en) 2012-09-19

Similar Documents

Publication Publication Date Title
EA201170199A1 (ru) Интравагинальные устройства с жёсткой подложкой, способы их получения и применения
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
AR078346A1 (es) Anticuerpos humanos de alta afinidad contra el receptor activado por proteasa de tipo 2 humano
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
RS53697B1 (en) TRICHODERMA ATROVIRIDE SC1 FOR BIOCONTROL OF FUNGAL DISEASES OF PLANTS
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
EP2334257A4 (en) BIONANO COMPOSITE FOR WEBEREGENERATION AND SOFTWARE SAVINGS
WO2009120386A3 (en) Novel solid forms of bendamustine hydrochloride
CL2008001114A1 (es) Compuestos derivados de bencimidazol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como vejiga sobreactiva, dolor, obesidad, convulsiones, entre otras.
EA201100084A1 (ru) Сшиваемая полимерная композиция
EA201001529A1 (ru) Способ и композиция для лечения mif-опосредованных расстройств
UA107672C2 (en) N-(1,2,5-oxadiazol-3-yl)benzamides and the use thereof as herbicides
MY181324A (en) Weighted elastomers, cement compositions comprising weighted elastomers, and methods of use
ECSP109923A (es) Bromhidrato de bupropion y aplicaciones terapéuticas
ATE499927T1 (de) Tablettierte atazanavirhaltige zusammensetzungen
ATE503467T1 (de) Tablettierte atazanavirhaltige zusammensetzungen
AR058173A1 (es) Uso de sdf-1 para el tratamiento y/o prevencion de enfermedades neurologicas
AU2010360764A8 (en) Micro devices biomedical applications and uses of the same
AR078323A1 (es) Tratamiento con fampridina de liberacion sostenida en pacientes con esclerosis multiple
AR066416A1 (es) Catalizador de deshidrogenacion, proceso de preparacion del mismo y proceso de deshidrogenacion de un hidrocarburo
AR060312A1 (es) Metodos para regular renalasa (monoamina oxidasa c)
EA201500501A1 (ru) Несущий корпус для лекарственного средства и способ его изготовления
ES2621824T3 (es) Uso de MicroRNA-199B-5P en el campo médico y de diagnóstico
ATE500820T1 (de) Tablettierte atazanavirhaltige zusammensetzungen
RU2009133559A (ru) Способ обработки деталей

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU